COVID-19 Weekly Newsletter: U.S. Eyes Third Wave as Scientific Understanding, FDA Actions Advance
By EsqSocial Corporation 26/10/20
As talks of a third wave of infections bubble up and political negotiations over another COVID-19 relief package continue to stall, the pressure is on for the health and life science fields to better understand and tamp down the current public health emergency. The Centers for Disease Control and Prevention (CDC) revised its stance on close contact after a case study investigation overturned previous understanding of cumulative exposure. At the same time, the Food and Drug Administration (FDA)...
By: Faegre Drinker Biddle & Reath LLP